Received by email:

File: '\\office\emailin\20220704 054240 Attachment 070422 BHSC NR 1,360,000 Stock options Approved Final.docx'

CSE:BHSC - FSE:8MV - OTC: CNVCF OFSE:8MV
NR: 070422-1

BIOHARVEST SCIENCES INC. ANNOUNCES GRANT OF STOCK OPTIONS




VANCOUVER, BC, July 4, 2022 - BioHarvest Sciences Inc. ("BioHarvest" or the "Company") (CSE: BHSC) announces that it h
--->as granted a total of 1,360,000 stock options to consultants and employees. The stock options granted are exercisable 
--->to purchase a common share of the Company at a price of $0.24 per share for a term of 10 years and will vest as follow
--->:

Amount of Stock Options Granted
Vesting Terms
35,000
Vesting monthly over a 2-month period
325,000
Vesting quarterly over a 3-year period
166,660
Vesting at once after six (6) months
833,340
Vesting monthly starting January 4, 2023, over a 2.5-year period

Dr. Zaki Rakib, Director of the Company, has agreed to cancel a total of 4,343,800 stock options previously issued to 
--->him on March 23, 2021. The Company now has more available options to attract and retain future employees, consultants,
---> directors, and officers of the Company by affording them the opportunity to acquire an interest in BHSC through optio
--->ns granted under the Incentive Option Plan.

About BioHarvest Sciences Inc.
BioHarvest Sciences Inc. (CSE: BHSC) is a fast-growing Biotech firm listed on the Canadian Securities Exchange. BioHar
--->vest has developed a patented bio-cell growth platform technology capable of growing the active and beneficial ingredi
--->ents in fruit and plants, at industrial scale, without the need to grow the plant itself. This technology is economica
--->l, ensures consistency, and avoids the negative environmental impacts associated with traditional agriculture. BioHarv
--->est is currently focused on nutraceuticals and the medicinal cannabis markets. Visit: www.bioharvest.com.

BioHarvest Sciences Inc.
Ilan Sobel, Chief Executive Officer

For further information, please contact:
Dave Ryan, VP Investor Relations & Director
Phone: 1 (604) 622-1186
Email: dave@bioharvest.com 

      


Forward-Looking Statements 
Information set forth in this news release includes forward-looking statements that are based on management's current 
--->estimates, beliefs, intentions, and expectations, and are subject to a number of risks and uncertainties that could ca
--->use actual results to differ materially from those described in the forward-looking statements. There is no assurance 
--->that we will achieve our objective of being a leading supplier of Cannabis. Delays and cost overruns may result in del
--->ays achieving our objectives. Projected sales of Cannabis will require the company to obtain production and / or expor
--->t licensing which cannot be assured.

All forward-looking statements are inherently uncertain and actual results may be affected by a number of material fac
--->tors beyond our control. Readers should not place undue reliance on forward-looking statements. BHSC does not intend t
--->o update forward-looking statement disclosures other than through our regular management discussion and analysis discl
--->osures. 

Neither the Canadian Securities Exchange nor its Regulation Services Provider accept responsibility for the adequacy o
--->r accuracy of this release.